00000000nam 22000008i 4500
0019.914268
003CaOODSP
00520221221135918
006m     o  d f      
007cr |||||||||||
008220809t20222022onc     o    f000 0 eng d
020 |a9780660449555
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-342/2022E-PDF
24500|aGuidance document : |bpost-notice of compliance changes - guidance for safety and efficacy of veterinary drugs.
24617|aPost-NOC changes for safety and efficacy for veterinary drugs
264 1|aOttawa, ON : |bHealth Canada = Santé Canada,|c2022.
264 4|c©2022
300 |a1 online resource (17 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : changements survenus après l’avis de conformité : lignes directrices sur l’innocuité et l’efficacité des médicaments vétérinaires.
500 |a"July 28, 2022."
500 |a"Pub.: 220365."
650 0|aDrugs|xLabeling|zCanada.
650 0|aDrug approval|zCanada.
650 0|aVeterinary drugs|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLigne directrice : |w(CaOODSP)9.914269
85640|qPDF|s1.28 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H164-342-2022-eng.pdf